Atlas Trials

Drug Sensitivity Correlation Between Patient-Derived Organoid Model and Clinical Response in NSCLC Patients

Clinical trial NCT03453307 · UNKNOWN

Trial details

NCT number
NCT03453307
Sponsor
K2 Oncology, Inc.
Status
UNKNOWN
Study type
OBSERVATIONAL
NSCLC
Start date
2018-01-30
Primary completion
2020-07-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.